An Enhanced Artificial Intelligence Breast MRI Scanning System (IntelliScan)

乳腺癌是全球女性最常见的癌症类型，2015年诊断出近170万例新病例（总体上是第二大常见癌症）。这约占所有新发癌症病例的12%和所有女性癌症的25%。根据世界卫生组织（2013年全球健康估计），超过50%的乳腺癌病例和42%的死亡发生在发达国家。在英国，每5例乳腺癌中就有1例死亡。因此，该项目旨在开发INTELLISCAN，一种人工智能，机器学习增强的乳腺MRI扫描系统，作为一种高效，更准确的乳腺癌筛查工具。我们的技术应用基于计算机的图像处理来提供改进的、即时的、自动化的乳房MRI扫描异常检测。"

"Breast cancer is the most common type of cancer in women worldwide, with nearly 1.7 million new cases diagnosed in 2015 (second most common cancer overall). This represents about 12% of all new cancer cases and 25% of all cancers in women. According to the World Health Organisation (Global Heath Estimates 2013), over 50% of breast cancer cases and 42% of deaths occur in developed countries. This includes the UK, where one in 5 cases of breast cancer results in a fatality.This project therefore seeks to develop INTELLISCAN, an Artificial Intelligence, machine learning enhanced breast MRI scanning system for use as a highly efficient, more accurate breast cancer screening tool. Our technology applies computer based image processing to deliver improved, instant, automated anomaly detection of breast MRI scans. "